#1

Portfolio, M&A, and Commercial Strategy

Kardam supports portfolio and product‑selection strategy in pharmaceuticals, aligning API capabilities, CGMP capacity, and commercial priorities. The firm also provides business‑case development and diligence support for mergers and acquisitions, including asset and platform evaluations, and assists with business development and licensing, carve‑outs, and integration of generic and API assets into existing pharmaceutical manufacturing platforms.

#2 Operational Turnarounds and Efficiency

The firm advises on operational turnarounds where performance, compliance, and service levels are critical to value. Engagements include multi‑year efficiency programs, yield and cost‑of‑goods improvements, and stabilizing CGMP manufacturing and supply chain performance under sponsor or corporate ownership.

#3 API and Drug Product Manufacturing

Kardam helps evaluate and design API and finished‑dose manufacturing networks across international, multi‑site operations. Work typically addresses network rationalization, site carve‑outs, CGMP readiness, and capital allocation to improve manufacturing efficiency and resilience in generic and branded drugs and APIs.

#4 Investor and Board Advisory

Kardam serves private equity firms, lenders, and boards seeking an independent operating view on pharmaceutical, API, and CDMO/CMO platforms. Typical mandates include investment and investment‑committee (IC) support, board‑level operating reviews, leadership and organization design at the CEO/COO/CCO level, and ongoing advisory roles for sponsors and strategic acquirers.

#5 Sectors and Focus Areas

Pharmaceuticals, including oral solid, sterile, special delivery systems, and high‑potency products
Active pharmaceutical ingredients, excipients, and intermediates
Pharmaceutical supply chain and CGMP manufacturing networks
CEO, COO, and CCO‑level leadership transitions and operating model design in complex organizations

API and Drug Product Manufacturing Strategies

Enhancing API and Drug Product Manufacturing for a Competitive Edge

Active Pharmaceutical Ingredients (APIs) and drug product manufacturing are at the heart of the pharmaceutical industry. Kardam Consulting provides strategic guidance to help companies optimize their manufacturing operations, improve efficiency, and stay ahead of the competition.

Our Services

We offer a comprehensive range of services, including:

Network Rationalization: Streamlining manufacturing networks to reduce costs and improve efficiency.
Site Carve-Outs: Assisting with the separation of non-core manufacturing sites.
Capital Allocation: Advising on strategic investments to enhance manufacturing capabilities.

Why Work with Kardam Consulting?

Our team has extensive experience in API and drug product manufacturing, with a deep understanding of the challenges and opportunities in this space. We provide tailored solutions that deliver tangible results.

Case Study: Optimizing API Manufacturing

In a recent engagement, we helped a pharmaceutical company rationalize its API manufacturing network, resulting in a 15% reduction in operating costs and improved production capacity.

Let’s Work Together

Looking to enhance your API and drug product manufacturing operations? Kardam Consulting is your trusted partner.

Contact us today to learn how we can help you achieve your manufacturing goals.